CATALAYER NEWS

Medtech M&A 'rebounded' in 2025 as softer valuations drove deal competition: report - Fierce Biotech

Source: Fierce Biotech · 2026-01-28

Full article text is available in the Catalayer news terminal.

RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsTech IPO & Private Market News
RELATED MARKETS
Prediction Markets
Xi Jinping out before 2027?5%Will Gavin Newsom win the 2028 Democratic presidential nomination?15%Will Alexandria Ocasio-Cortez win the 2028 Democratic presidential nomination?23%
Open Catalayer terminal for live tracking →